2014 Healthcare Technologies Resource Guide- A Reference for U.S. Exporters to Global Markets
This guide provides a matrix of projected successes of sub-sector exports to over 40 countries as well as country specific information on foreign markets for Healthcare Technologies. Each individual country analysis details market entry information along with current market trends.
Health IT Industry Page
According to the World Bank, the global Health IT industry is expected to grow to $250 billion dollars by 2015. This presents a tremendous opportunity for U.S. businesses to compete in the Health IT sector. Take a look at this excellent new resource featuring market intelligence, events and monthly sector highlights!
Medical Technology Europe Guide 2014
The healthcare industry in Europe is highly advanced, innovative, and there is a constant demand for cutting edge, high-tech products. In both new and existing technologies, U.S. exporters will find a wealth of opportunities on the European market.
Privatization of Healthcare in the Yangtze River Delta: Hospital and Elder Care Submarkets
This September 2013 report, prepared by U.S. Commercial Service Shanghai, outlines the tremendous opportunity for American businesses to discover the booming markets for healthcare services (senior care), medical devices (components), and pharmaceuticals.
Snapshot: The German Pharmaceutical Industry
This February 2013 report, prepared by U.S. Commercial Service Dusseldorf commercial specialist Anette Salama, provides updated information and statistics, including top markets supplying pharmaceuticals to Germany, top indications, and major trade shows.
Medical Device Markets Europe
Overview of medical device sales in Europe, as presented by Business Monitor session at MEDTEC Europe in Stuttgart, Germany (February 2013)
German Life Sciences Trend Analysis 2012
This report, prepared and owned by Biotechgate.com, features in-depth information on the biotechnology sector in Germany, and compares the sector in Germany to select European markets.
Pharmaceutical Price Control in OECD Countries- Implications for U.S. Consumers, Pricing, Research and Development, and Innovation
This report details the effect of price controls imposed by various U.S. trade partners on pharmaceutical prices, R&D, innovation, and U.S. consumers. The study examines the drug price regulatory systems, and includes a qualitative analysis of prices, revenues, and R&D implications for the OECD countries analyzed.